Cyclin-dependent kinases and stroke

Author： Park David S   Wang Fuhu   O’Hare Michael J  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.5, Iss.5, 2001-10, pp. : 557-567

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of Cyclin-Dependent Kinases as Anti-Cancer Therapeutics

By  

Current Medicinal Chemistry, Vol. 7, Iss. 12, 2000-12 ,pp. : 1213-1245

Bentham Science Publishers

Access to resources Recommend Favorite

Seliciclib, a cell-cycle modulator that acts through the inhibition of cyclin-dependent kinases

By Jackson Robert C   Barnett Anna L   McClue Steven J   Green Simon R  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 1, 2008-01 ,pp. : 131-143

Informa Healthcare

Access to resources Recommend Favorite

Cyclin-dependent protein kinases as therapeutic drug targets for antimalarial drug development

By Waters Norman C   Geyer Jeanne A  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 1, 2003-02 ,pp. : 7-17

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of Cyclin-Dependent Kinases: Potential Drugs for the Treatment of Neurodegenerative Disorders?

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 2, 2005-01 ,pp. : 101-109

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclin-dependent protein kinases as therapeutic targets in cardiovascular disease

By Edo María Dolores   Roldán Marta   Andrés Vicente  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 5, 2003-05 ,pp. : 579-588

Informa Healthcare

Access to resources Recommend Favorite